Hans-peter P. Horny

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 99 publications

Mast Cell Activation Syndrome: Quantification of Mast Cells Across Conditions Reveals Limited Diagnostic Utility of Mast Cell Counts and Tryptase Depletion Index.

Mast Cell Activation Syndrome: Quantification of Mast Cells Across Conditions Reveals Limited Diagnostic Utility of Mast Cell Counts and Tryptase Depletion Index.

Journal: Archives of pathology & laboratory medicine

Published: January 27, 2026

Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts.

Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts.

Journal: American journal of hematology

Published: May 30, 2025

Leukocytosis, Monocytosis, and Eosinophilia in Systemic Mastocytosis: Analysis of Phenotype, Genetics and Prognosis in 596 Patients From the GREM Registry.

Leukocytosis, Monocytosis, and Eosinophilia in Systemic Mastocytosis: Analysis of Phenotype, Genetics and Prognosis in 596 Patients From the GREM Registry.

Journal: The journal of allergy and clinical immunology. In practice

Published: May 23, 2025

The number of vertebral fractures in indolent systemic mastocytosis is influenced by presence of the KIT-mutation.

The number of vertebral fractures in indolent systemic mastocytosis is influenced by presence of the KIT-mutation.

Journal: Bone

Published: February 19, 2025

Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM.

Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM.

Journal: The journal of allergy and clinical immunology. In practice

Published: July 12, 2024

Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in KIT D816V-Negative Advanced Systemic Mastocytosis.

Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in KIT D816V-Negative Advanced Systemic Mastocytosis.

Journal: Cancers

Published: December 11, 2023

World Health Organization Classification and Diagnosis of Mastocytosis: Update 2023 and Future Perspectives.

World Health Organization Classification and Diagnosis of Mastocytosis: Update 2023 and Future Perspectives.

Journal: Immunology and allergy clinics of North America

Published: September 27, 2023

Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts.

Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts.

Journal: International journal of molecular sciences

Published: September 15, 2023

A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosis.

A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosis.

Journal: Scientific reports

Published: May 18, 2023

The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT.

The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT.

Journal: The journal of allergy and clinical immunology. In practice

Published: May 03, 2023

Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome.

Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome.

Journal: British journal of haematology

Published: April 15, 2023

European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives.

European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives.

Journal: The journal of allergy and clinical immunology. In practice

Published: November 28, 2022

Showing 1-12 of 99

Last Updated: 09/26/2026